We're excited to highlight another landmark achievement in our growing Brazilian portfolio: OBN Capital is leading a potential private equity transaction for Cimed, one of Brazil's most dynamic and innovative pharmaceutical groups, as the company pivots toward accelerated growth and strategic expansion.
Cimed, a family-controlled leader founded in 1977 and headquartered in São Paulo, has transformed the Brazilian health and wellness landscape. With a fully verticalized model—from R&D and manufacturing to direct distribution—the company excels in pharmaceuticals, vitamins and nutrition, beauty and hygiene, medicines, and dermo-cosmetic products. Under CEO João Adibe Marques' visionary leadership, Cimed has built a powerhouse brand, recently welcoming Singapore's sovereign wealth fund GIC as a minority investor in what was hailed as the largest private healthcare deal in Brazil over the past decade. That partnership fuels "Cimed’s New Era," aiming to triple revenues through innovation, technology, new ventures, and inorganic growth.
Building on this momentum, Cimed is now exploring further capital to support ambitious plans—including factory expansions (such as the recent R$90 million investment in Pouso Alegre to boost capacity by 30%), potential acquisitions, and broader market penetration. OBN Capital is proud to serve as the lead advisor in structuring and facilitating this next fundraising round, acting as the key intermediary to connect high-caliber investors with Cimed's compelling growth story.
This deal represents a strategic pivot from mainstream media narratives, focusing instead on high-impact private market opportunities in Brazil's booming healthcare sector. Our team's deep regional expertise, combined with our São Paulo hub, positions us ideally to navigate complex transactions and deliver optimal outcomes for both Cimed and incoming partners.
As Brazil's pharmaceutical and consumer health market continues to expand rapidly—driven by rising demand for accessible, high-quality wellness solutions—we're thrilled to play a pivotal role in enabling Cimed to scale even further, create value, and continue delivering health and well-being to millions of Brazilians.
This collaboration reinforces OBN Capital's commitment to transformative investments in Latin America's most promising sectors, particularly healthcare and consumer goods.
Stay tuned for developments as we advance this exciting opportunity together.
